Immunotherapy

Immunotherapy is the concept of using the immune system to treat disease, for example, developing a vaccine against cancer. Immunotherapy may also refer to the therapy of diseases caused by the immune system, allergies for example.

What is Immunotherapy?

Immunotherapy is a treatment that is designed to harness the ability of the body’s immune system to combat infection or disease.

Adoptive T Cell Therapy Methodology

Neoantigens' Role in Immunotherapy

Immunotherapy and Helminthic Therapy

Immunotherapy: The Future of Lung Cancer Treatment?

Adoptive T Cell Therapy Applications

Suppression Immunotherapies

Activation Immunotherapies

Immunotherapy: Past, Present and Future

Latest Immunotherapy News and Research

Red blood cells inspire next-generation therapeutic nanocarriers

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

19 Aug 2026

UC Irvine researchers develop framework to make CAR T-cell therapy safer

CAR T-cell therapy has transformed cancer care, offering new hope to patients with aggressive blood cancers who once had few treatment options.

18 Aug 2026

Exhausted T cells can escape tumors and confer long-lasting immunity to cancer in mice

As the immune system battles cancer, chronic stimulation gradually drives T cells to a state of exhaustion.

18 Aug 2026

New study links chronic stress to immunotherapy resistance in tumors

Immunotherapy has transformed cancer treatment, yet many tumors remain stubbornly resistant to its effects.

18 Aug 2026

Study provides new insights into how IL-26 reshapes the tumor immune landscape

While cancer cells acquire malignant traits through epigenetic remodeling, it remains unclear how immune-derived inflammatory factors regulate the epigenetics of colorectal cancer cells.

18 Aug 2026

Engineered red blood cell vesicles improve gene therapy delivery

Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments.

17 Aug 2026

PolyU develops AI Virtual Patient Simulation System for precision cancer care

A research team at The Hong Kong Polytechnic University (PolyU) has developed a patient-centric "Artificial Intelligence (AI) Virtual Patient Simulation System", overcoming the limitations of conventional static diagnosis.

14 Aug 2026

Outfitting cells in "invisibility cloaks" could offer a novel approach to treating diabetes

Outfitting cells in "invisibility cloaks" may offer an easier, less damaging treatment pathway for people with diabetes undergoing cell therapy, according to researchers at Penn State.

14 Aug 2026

Ultrasound-guided SHIFTERS could expand CAR-T therapy for solid tumors

For more than a decade, CAR-T cell therapy has been one of the biggest breakthroughs in cancer medicine.

13 Aug 2026

Study uncovers hidden switch that helps cancer cells to evade immune detection

Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) have uncovered a previously unknown mechanism that helps cancer cells evade detection by the body's immune system.

13 Aug 2026

Preoperative combination therapy improves head and neck cancer outcomes

Patients with head and neck cancer who received chemotherapy in addition to immunotherapy before surgery had a significantly reduced tumor size at the time of operation than patients who received immunotherapy alone.

13 Aug 2026

Bacterial extracellular vesicles show potential for cancer diagnosis and treatment

Bacteria shed membrane-enclosed tiny particles filled with proteins, lipids, DNA, RNA and metabolites. These particles, commonly known as bacterial extracellular vesicles (BEVs), are now being explored as possible tools for cancer diagnosis and treatment.

13 Aug 2026

Cannabis compounds may weaken glioblastoma response to chemotherapy and radiation

Several cannabinoids reduced chemotherapy- and radiation-induced apoptosis in glioblastoma cell models, with effects linked to reduced apoptotic priming, increased pro-survival signaling, and G1 cell-cycle arrest. The findings raise concern that cannabinoid exposure could interfere with some cancer treatments, although the results are limited to laboratory models and require in vivo and clinical validation.

12 Aug 2026

Genetic tool turns soft cancer cells into immune targets

Researchers at the USC Viterbi School of Engineering and Keck School of Medicine of USC have engineered a remarkable genetic tool that addresses one of the most persistent obstacles in cancer immunotherapy: the physical softness of tumors.

11 Aug 2026

New human tissue chips aim to replace animal testing

Animal testing has long been the standard for evaluating new drugs before they reach human patients. But when it comes to cancer immunotherapy drugs, animal models often fail to predict which immunotherapies might produce harmful side effects in humans because they do not have the same responses or the same cell receptors.

11 Aug 2026

HonorHealth begins trial of dendritic cell vaccine for advanced melanoma

Physicians at HonorHealth Research Institute have begun a clinical trial of a new, potentially more powerful, treatment for fighting advanced melanoma, using the immune system's dendritic cells to create a vaccine.

11 Aug 2026

Lab-grown mini tumors help scientists predict breast cancer treatment success

Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown mini tumors.

11 Aug 2026

New gene signature predicts immunotherapy success for bone marrow cancers

A team led by researchers from the German Cancer Research Center (DKFZ), the HI-STEM Stem Cell Institute, and Medical Clinic V at Heidelberg University Hospital (UKHD) has characterized T cells in the bone marrow in cases of multiple myeloma and acute myeloid leukemia: A specific group of tumor-reactive T cells can recognize and, in principle, fight cancer cells, but is often not sufficiently activated.

10 Aug 2026

Immune cell interaction timing impacts glioblastoma treatment response

A joint research team led by Professor Sungsu Park of Sungkyunkwan University and Professor Sun-Ha Paek of Seoul National University College of Medicine has demonstrated for the first time that the sequence in which immune cells interact with cancer cells can critically influence the therapeutic response in glioblastoma.

10 Aug 2026